Azithromycin and early allograft function after lung transplantation: a randomized controlled trial

Chronic lung allograft dysfunction (CLAD) is the single most important factor limiting long-term survival after lung transplantation (LTx). Azithromycin has been shown to improve CLAD-free and long-term survival, yet the possible impact on early lung allograft function is unclear.

Source: The Journal of Heart and Lung Transplantation - December 14, 2018 Category: Transplant Surgery Authors: Anke Van Herck, Anna E. Frick, Veronique Schaevers, Dr. Annelies Vranckx, Eric K. Verbeken, Bart M. Vanaudenaerde, Annelore Sacreas, Tobias Heigl, Arne P. Neyrinck, Dirk Van Raemdonck, Lieven J. Dupont, Jonas Yserbyt, Stijn E. Verleden, Geert M. Verleden, Tags: Original Clinical Science Source Type: research